$JHX

Rowland Suzanne B purchased $69K of JHX

Rowland Suzanne B purchased 3,000 shares of James Hardie Industries plc (JHX) at $22.91 on 2026-06-02.

Original reporting
SEC EDGAR · Rowland Suzanne B
Published Jun 3, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JHX
Bullish
low confidence
Mentioned
$JHX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBullishLow
01

Why it matters

The disclosure may slightly improve sentiment/positioning for JHX, but it does not provide new guidance, earnings, or deal information.

02

Market read

Traders may note the insider buy as a small positive signal, but it is unlikely to be a standalone catalyst.

03

What to watch

No 10b5-1 plan is stated, but the article provides no context on prior buying/selling patterns or total insider exposure changes.

Relevance 6/10Novelty 6/10Timing: Filed after-hours on 2026-06-03; reflects trades executed 2026-06-02.

Background

This is an SEC Form 4 insider transaction disclosure (director open-market purchase) for James Hardie Industries plc.

Company-level read

Ticker impact

$JHXBullishLow confidence
Context

Director Rowland Suzanne B bought 3,000 shares of James Hardie (JHX) for ~$68.7K via an open-market purchase disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect is small and sentiment-driven.

Evidence & confidence

The filing reports a single director purchase size (~$68.7K) with no 10b5-1 plan and no accompanying operational/financial news.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated beyond JHX-specific sentiment.

None indicated.

Counterpoint

Director buying can be routine (compensation-related or personal liquidity needs) and may not imply near-term upside.

Key entities

  • James Hardie Industries plc

    Subject of the Form 4 insider purchase disclosure.

  • Rowland Suzanne B

    Director who purchased 3,000 JHX shares on 2026-06-02.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JHXMedAI 8/10

James Hardie (JHX) Crushes Guidance and Raises Its Full-Year Outlook

James Hardie (JHX) reported Q1 FY2027 results with net sales up 64% YoY to $1.475B, adjusted EBITDA up 79% to $422.1M, and raised full-year guidance. The company cited strong execution, cost synergies from the AZEK acquisition, and share gains in its core business. CEO Aaron Erter noted the beat was not due to housing market improvement. Free cash flow doubled to $254.2M, used to pay down debt. Shares trade at a forward P/E of 21.79.

$JHXMed

James Hardie upgrades FY27 cash flow guidance but not earnings, shares dip 5%

James Hardie (JHX) raised its FY27 free cash flow guidance by 20% to ~US$600M, but shares fell 5% as sales and earnings guidance remained unchanged. The company expects to achieve US$125M in cost synergies a year ahead of schedule. Management stated the guidance does not assume a housing recovery. FY26 free cash flow was US$425M, after deal and integration costs of ~US$207M.